PressreleaserPå svenska

2022-10-31

Duearity will submit an application for approval of a tinnitus product in the United States

Read more

Regulatorisk

2021-11-02

Duearity to develop AI solution for people suffering from tinnitus

Read more

Regulatorisk

Finansiell kalender

  • Delårsrapport kvartal 1 2022: 5 maj 2022.
  • Halvårsrapport 2022: 25 augusti 2022.
  • Kvartalsrapport 3 2022: 17 november 2022.
  • Bokslutskommuniké 2022: 23 februri 2023.
  • Delårsrapport kvartal 1 2023: 4 maj 2023.

IR-kontakt

  • Fredrik Westman, VD
  • Stillmansgatan 12, 211 25, Malmö
  • fredrik.westman@duearity.com
  • +46 (0) 738 145215